LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $21,510 | -22.4% | 322 | 0.0% | 0.01% | -27.3% |
| Q3 2022 | $27,727 | -3.2% | 322 | +0.3% | 0.01% | 0.0% |
| Q2 2022 | $28,640 | -20.7% | 321 | 0.0% | 0.01% | -8.3% |
| Q1 2022 | $36,109 | +10.3% | 321 | +51.4% | 0.01% | +9.1% |
| Q4 2021 | $32,746 | -11.0% | 212 | -19.7% | 0.01% | -21.4% |
| Q3 2021 | $36,780 | -54.3% | 264 | -9.9% | 0.01% | -73.6% |
| Q3 2018 | $80,426 | +56.5% | 293 | +18.1% | 0.05% | +47.2% |
| Q2 2018 | $51,378 | +25.4% | 248 | 0.0% | 0.04% | +24.1% |
| Q1 2018 | $40,960 | +20.6% | 248 | 0.0% | 0.03% | +16.0% |
| Q4 2017 | $33,959 | +0.6% | 248 | 0.0% | 0.02% | -3.8% |
| Q3 2017 | $33,765 | +12.1% | 248 | 0.0% | 0.03% | +8.3% |
| Q2 2017 | $30,107 | +37.4% | 248 | +19.8% | 0.02% | +33.3% |
| Q1 2017 | $21,909 | +4.2% | 207 | 0.0% | 0.02% | -5.3% |
| Q4 2016 | $21,033 | -0.4% | 207 | 0.0% | 0.02% | 0.0% |
| Q3 2016 | $21,126 | -14.4% | 207 | 0.0% | 0.02% | -17.4% |
| Q2 2016 | $24,689 | +11.4% | 207 | 0.0% | 0.02% | +9.5% |
| Q1 2016 | $22,168 | – | 207 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 1,249,766 | $58,726,504,000 | 11.17% |
| BVF INC/IL | 1,108,763 | $52,101,000 | 10.82% |
| GROW Partners, LLC | 132,500 | $6,226,000 | 5.58% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 936,825 | $44,021,000 | 2.73% |
| First Light Asset Management, LLC | 76,366 | $3,588,000 | 2.45% |
| Healthcare Value Capital, LLC | 50,000 | $2,350,000 | 2.27% |
| OBERWEIS ASSET MANAGEMENT INC/ | 168,337 | $7,910,000 | 2.17% |
| RK Capital | 174,283 | $8,190,000 | 1.67% |
| Nichols Asset Management LLC | 133,368 | $6,267,000 | 1.30% |
| ASHFORD CAPITAL MANAGEMENT INC | 108,289 | $5,089,000 | 1.09% |